SATI PATEL

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease PLANO, TX NPI 1013370659

General Payments — all program years on this page

$2,305.74

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 85
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,073.63 across 38 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,073.6338

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $98.061
2022 $145.027
2023 $989.0339
2024 $1,073.6338

Records — PY2024 (38)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1080696000 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $29.23 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080696002 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $24.03 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087190897 Novartis Pharmaceuticals Corporation $19.15 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087190899 Novartis Pharmaceuticals Corporation $18.37 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087190901 Novartis Pharmaceuticals Corporation $17.43 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087190903 Novartis Pharmaceuticals Corporation $4.28 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087190905 Novartis Pharmaceuticals Corporation $21.06 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087190923 Novartis Pharmaceuticals Corporation $26.42 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087190925 Novartis Pharmaceuticals Corporation $24.49 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087190929 Novartis Pharmaceuticals Corporation $17.64 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087190931 Novartis Pharmaceuticals Corporation $16.20 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087190933 Novartis Pharmaceuticals Corporation $30.71 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087190935 Novartis Pharmaceuticals Corporation $18.88 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087190937 Novartis Pharmaceuticals Corporation $23.22 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087190939 Novartis Pharmaceuticals Corporation $33.83 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087190941 Novartis Pharmaceuticals Corporation $17.61 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087190943 Novartis Pharmaceuticals Corporation $14.28 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087190945 Novartis Pharmaceuticals Corporation $13.32 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087190947 Novartis Pharmaceuticals Corporation $22.39 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087190949 Novartis Pharmaceuticals Corporation $11.43 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096923142 Novo Nordisk Inc $21.49 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096928306 Novo Nordisk Inc $16.07 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097308475 Novo Nordisk Inc $31.27 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097427448 Novo Nordisk Inc $19.66 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097597288 Novo Nordisk Inc $14.28 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101353226 E.R. Squibb & Sons, L.L.C. $16.34 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101353238 E.R. Squibb & Sons, L.L.C. $16.85 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104672329 AstraZeneca Pharmaceuticals LP $24.26 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116001964 Amgen Inc. $29.21 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116001970 Amgen Inc. $16.12 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116558009 GlaxoSmithKline, LLC. $13.40 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117836702 Boehringer Ingelheim Pharmaceuticals, Inc. $15.03 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133856472 CVRx, Inc. $19.48 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133856474 CVRx, Inc. $40.91 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133856476 CVRx, Inc. $27.89 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138843361 Edwards Lifesciences Corporation $181.36 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142292913 ABIOMED $142.07 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154884522 Kiniksa Pharmaceuticals International, plc $23.97 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.